Treasurer of the State of North Carolina’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $52.9M | Buy |
872,508
+18,588
| +2% | +$1.08M | 0.17% | 104 |
|
|
2025
Q4 | $46.1M | Sell |
853,920
-62,391
| -7% | -$3M | 0.15% | 121 |
|
|
2025
Q3 | $41.3M | Sell |
916,311
-35,702
| -4% | -$1.67M | 0.13% | 141 |
|
|
2025
Q2 | $44.1M | Buy |
952,013
+23,364
| +3% | +$1.15M | 0.14% | 134 |
|
|
2025
Q1 | $56.6M | Sell |
928,649
-121,659
| -12% | -$7.09M | 0.23% | 85 |
|
|
2024
Q4 | $59.4M | Sell |
1,050,308
-15,910
| -1% | -$889K | 0.23% | 76 |
|
|
2024
Q3 | $55.2M | Buy |
1,066,218
+10,400
| +1% | +$488K | 0.22% | 80 |
|
|
2024
Q2 | $43.8M | Sell |
1,055,818
-15,850
| -1% | -$709K | 0.19% | 97 |
|
|
2024
Q1 | $58.1M | Buy |
1,071,668
+13,830
| +1% | +$705K | 0.26% | 75 |
|
|
2023
Q4 | $54.3M | Sell |
1,057,838
-4,996
| -0.5% | -$262K | 0.26% | 71 |
|
|
2023
Q3 | $61.7M | Buy |
1,062,834
+16,071
| +2% | +$985K | 0.33% | 53 |
|
|
2023
Q2 | $66.9M | Buy |
1,046,763
+21,738
| +2% | +$1.46M | 0.35% | 47 |
|
|
2023
Q1 | $71M | Buy |
1,025,025
+19,202
| +2% | +$1.35M | 0.4% | 42 |
|
|
2022
Q4 | $72.4M | Buy |
1,005,823
+42,629
| +4% | +$3.21M | 0.44% | 36 |
|
|
2022
Q3 | $68.5M | Buy |
963,194
+8,970
| +0.9% | +$651K | 0.45% | 37 |
|
|
2022
Q2 | $73.5M | Sell |
954,224
-6,463
| -0.7% | -$492K | 0.46% | 38 |
|
|
2022
Q1 | $70.2M | Sell |
960,687
-20,230
| -2% | -$1.36M | 0.39% | 50 |
|
|
2021
Q4 | $61.2M | Buy |
980,917
+5,140
| +0.5% | +$302K | 0.32% | 57 |
|
|
2021
Q3 | $57.7M | Buy |
975,777
+2,520
| +0.3% | +$166K | 0.33% | 57 |
|
|
2021
Q2 | $65M | Sell |
973,257
-19,110
| -2% | -$1.25M | 0.38% | 50 |
|
|
2021
Q1 | $62.6M | Buy |
992,367
+3,210
| +0.3% | +$200K | 0.39% | 53 |
|
|
2020
Q4 | $61.4M | Buy |
989,157
+4,130
| +0.4% | +$254K | 0.41% | 49 |
|
|
2020
Q3 | $59.4M | Buy |
985,027
+3,490
| +0.4% | +$210K | 0.45% | 44 |
|
|
2020
Q2 | $57.7M | Sell |
981,537
-181,250
| -16% | -$10.8M | 0.48% | 42 |
|
|
2020
Q1 | $64.8M | Buy |
1,162,787
+81,420
| +8% | +$4.98M | 0.58% | 33 |
|
|
2019
Q4 | $69.4M | Buy |
1,081,367
+329,377
| +44% | +$18.9M | 0.58% | 34 |
|
|
2019
Q3 | $38.1M | Sell |
751,990
-308,240
| -29% | -$14.5M | 0.34% | 65 |
|
|
2019
Q2 | $48.1M | Sell |
1,060,230
-8,660
| -0.8% | -$403K | 0.3% | 72 |
|
|
2019
Q1 | $51M | Buy |
1,068,890
+3,917
| +0.4% | +$195K | 0.33% | 67 |
|
|
2018
Q4 | $55.4M | Buy |
1,064,973
+12,035
| +1% | +$647K | 0.4% | 56 |
|
|
2018
Q3 | $65.4M | Buy |
1,052,938
+379,083
| +56% | +$22.5M | 0.41% | 53 |
|
|
2018
Q2 | $37.3M | Buy |
673,855
+418,037
| +163% | +$22.6M | 0.39% | 60 |
|
|
2018
Q1 | $16.2M | Buy |
255,818
+251,116
| +5,341% | +$16.2M | 0.42% | 48 |
|
|
2017
Q4 | $288K | Buy |
+4,702
| New | +$294K | 0.71% | 48 |
|
Other funds holding BMY
VCM
VPM
Treasurer of the State of North Carolina's BMY Position: Q1 2026 in Review
Treasurer of the State of North Carolina increased its Bristol-Myers Squibb (BMY) stake by 2.2% in Q1 2026, buying an estimated $1.08M and bringing the position to 872,508 shares worth $52.9M. The position accounts for 0.17% of the portfolio, ranked #104.
Treasurer of the State of North Carolina first reported a position in BMY in Q4 2017 and has held it in 34 quarters since. The position peaked at $73.5M in Q2 2022. 2,528 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Treasurer of the State of North Carolina held 872,508 shares of Bristol-Myers Squibb worth $52.9M as of Q1 2026.
- Treasurer of the State of North Carolina bought 18,588 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.08M.
- Bristol-Myers Squibb made up 0.17% of Treasurer of the State of North Carolina's portfolio in Q1 2026, its #104 holding.
- Treasurer of the State of North Carolina first reported a position in Bristol-Myers Squibb in Q4 2017 and has held it in 34 quarters since.
- Treasurer of the State of North Carolina's Bristol-Myers Squibb position peaked at $73.5M in Q2 2022.
- 2,528 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Treasurer of the State of North Carolina's 13F filing for Q1 2026, filed 14 May 2026.